Status:
UNKNOWN
Added Value of the Oculomotor and Cognitive Examination in the Management of Patients With ADHD
Lead Sponsor:
Centre Hospitalier Rouffach
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
7-50 years
Phase:
NA
Brief Summary
ADHD is a neurodevelopmental disorder characterized by symptoms of inattention and / or hyperactivity-impulsivity that affects nearly 6% of school-aged children and persists into adulthood. More and m...
Detailed Description
Type of study and experimental plan: This is an interventional study designed to evaluate routine care. Number of Necessary Subjects Participants will be stratified by age to control the effect of ag...
Eligibility Criteria
Inclusion
- ADHD diagnosis according to DSM-IV-TR criteria
- Beneficiary of a social security scheme
- Having undergone an oculomotor examination as part of their usual care
- Normal neurological examination
Exclusion
- Intellectual Disability (IQ \< 70)
- Proven neurological pathology or identified genetic syndrome
- Vestibular pathology
- Ear, nose, and throat (ENT) pathology
- Neuro-ophthalmological pathology uncorrected by corrective glass (\<10/10 in binocular vision
Key Trial Info
Start Date :
February 17 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03411434
Start Date
February 17 2014
End Date
December 31 2019
Last Update
January 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Rouffach
Rouffach, Alsace, France, 68250